---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-25-000047"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T23:01:20.898161+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nautilus Biotechnology receives Nasdaq bid price deficiency notice; has until Oct 28, 2025 to regain compliance.

## Summary
- Received notice on May 1, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days through April 30, 2025.
- Has 180 calendar days (until October 28, 2025) to regain compliance; stock continues trading.
- To cure, closing bid price must be at least $1.00 for ten consecutive business days during the Compliance Period.
- If not compliant, may qualify for additional 180 days by transferring to Nasdaq Capital Market and meeting other requirements.
- No immediate delisting; company evaluating options but no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001808805-25-000047
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880525000047/0001808805-25-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880525000047/naut-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-25-000047
- JSON: https://secwatch.observer/filing/0001808805-25-000047.json
- Plain text: https://secwatch.observer/filing/0001808805-25-000047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.